2009
DOI: 10.1016/j.jevs.2009.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Medroxyprogesterone Acetate in Suppression of Estrus in Cycling Mares

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 21 publications
0
7
0
Order By: Relevance
“…Suppressing reproductive function and associated oestrous behaviour in mares has been managed by several approaches. Pharmacological methods utilising progesterone or progestins and potentially reversible GnRH‐agonist or ‐antagonist therapy and their associated shortcomings including costs, practicality and potential negative side effects are reported [1–3]. Surgical ovariectomy is generally considered to be undesirable, due to its associated risks and irreversible loss of breeding potential [4].…”
Section: Introductionmentioning
confidence: 99%
“…Suppressing reproductive function and associated oestrous behaviour in mares has been managed by several approaches. Pharmacological methods utilising progesterone or progestins and potentially reversible GnRH‐agonist or ‐antagonist therapy and their associated shortcomings including costs, practicality and potential negative side effects are reported [1–3]. Surgical ovariectomy is generally considered to be undesirable, due to its associated risks and irreversible loss of breeding potential [4].…”
Section: Introductionmentioning
confidence: 99%
“…The use of MPA in mares has occurred, but results and effectiveness vary. Gee et al, (2009) found that administration of compounded MPA starting on day 7 with 1,600 mg MPA intramuscularly and continuing with 400 mg on days 14, 21, 28, 35, and 42 had no effect on estrous behavior, nor follicular development, serum progesterone or LH concentrations.…”
Section: Medroxyprogesterone Acetatementioning
confidence: 91%
“…Such a product (Readyserv 2 ) is currently licensed in Australia. The use of medroxyprogesterone acetate (MPA) has been shown to be ineffective in suppressing oestrus in mares [3,12,13]. Repeated injections with low dose intravenous [14] or high dose intramuscular [15] oxytocin prolongs dioestrus (thereby suppressing oestrus) in up to 70% of mares.…”
Section: Introductionmentioning
confidence: 99%